FDG PET versus 67Ga scintigraphy as prognostic test during chemotherapy for non hodgkin’s lymphoma

@inproceedings{Zijlstra2011FDGPV,
  title={FDG PET versus 67Ga scintigraphy as prognostic test during chemotherapy for non hodgkin’s lymphoma},
  author={Jos{\'e}e M Zijlstra and Otto S. Hoekstra and Pieter G.H.M. Raijmakers and Emile F. I. Comans and Jacobus J. M. van der Hoeven and Gerrit J. J. Teule and Andries R Jonkhoff and Harm van Tinteren and Adriaan A. Lammertsma and Peter C. Huijgens},
  year={2011}
}
For response monitoring of aggressive non-Hodgkin’s lymphoma during treatment, a prospective study was performed comparing gallium scintigraphy (67Ga) and positron emission tomography (PET) using fluorine-18 fluorodeoxyglucose (FDG). In 26 patients 67Ga and FDG scans were performed following two cycles of CHOP.Scans were reviewed by 4 experienced nuclear physicians, independently and blinded for the alternative scan technique and follow-up. Eleven out of 26 patients remained free from… CONTINUE READING

Figures and Tables from this paper.

References

Publications referenced by this paper.
SHOWING 1-10 OF 33 REFERENCES

Diffuse large-cell lymphoma.

  • Annals of oncology : official journal of the European Society for Medical Oncology
  • 2000

Positron emission tomography for detection and staging of malignant lymphoma.

  • Recent results in cancer research. Fortschritte der Krebsforschung. Progres dans les recherches sur le cancer
  • 2000